GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (NSE:PANACEABIO) » Definitions » Receivables Turnover

Panacea Biotec (NSE:PANACEABIO) Receivables Turnover : 2.34 (As of Sep. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Panacea Biotec Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Panacea Biotec's Revenue for the three months ended in Sep. 2024 was ₹1,474 Mil. Panacea Biotec's average Accounts Receivable for the three months ended in Sep. 2024 was ₹630 Mil. Hence, Panacea Biotec's Receivables Turnover for the three months ended in Sep. 2024 was 2.34.


Panacea Biotec Receivables Turnover Historical Data

The historical data trend for Panacea Biotec's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec Receivables Turnover Chart

Panacea Biotec Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.83 8.06 7.93 6.45 9.39

Panacea Biotec Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.86 1.96 2.25 2.02 2.34

Competitive Comparison of Panacea Biotec's Receivables Turnover

For the Biotechnology subindustry, Panacea Biotec's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panacea Biotec's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacea Biotec's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Panacea Biotec's Receivables Turnover falls into.



Panacea Biotec Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Panacea Biotec's Receivables Turnover for the fiscal year that ended in Mar. 2024 is calculated as

Receivables Turnover (A: Mar. 2024 )
=Revenue / Average Total Inventories
=Revenue (A: Mar. 2024 ) / ((Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count )
=5519.29 / ((600.92 + 574.19) / 2 )
=5519.29 / 587.555
=9.39

Panacea Biotec's Receivables Turnover for the quarter that ended in Sep. 2024 is calculated as

Receivables Turnover (Q: Sep. 2024 )
=Revenue / Average Total Inventories
=Revenue (Q: Sep. 2024 ) / ((Accounts Receivable (Q: Jun. 2024 ) + Accounts Receivable (Q: Sep. 2024 )) / count )
=1473.5 / ((0 + 630.2) / 1 )
=1473.5 / 630.2
=2.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Panacea Biotec  (NSE:PANACEABIO) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Panacea Biotec Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacea Biotec Business Description

Traded in Other Exchanges
Address
Mathura Road, B-1 Extension/G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec Headlines

No Headlines